Brief: Anixa Biosciences And Ontochem Enter Next Stage Of Development For Covid-19 Therapeutic
05/04/2021 13:33
April 5 (Reuters) - Anixa Biosciences Inc ANIX.O :
* ANIXA BIOSCIENCES AND ONTOCHEM ENTER NEXT STAGE OF
DEVELOPMENT
FOR COVID-19 THERAPEUTIC
* ANIXA BIOSCIENCES INC - IT WILL PROGRESS TO NEXT STAGE OF
DEVELOPMENT OF ITS POTENTIAL ANTI-VIRAL THERAPY FOR COVID-19
Source text for Eikon: ID:nPn8jvmCva
Further company coverage: ANIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine